Why the study?
HPSD ablation is emerging as an alternative to conventional ablation for AF, but clinical studies validating its potential advantages remain limited.
Does high-power, short-duration radiofrequency ablation improve safety and efficacy compared to conventional ablation in patients with atrial fibrillation?
Does high-power, short-duration radiofrequency ablation improve safety and efficacy compared to conventional ablation in patients with atrial fibrillation?
High-power, short-duration ablation is an emerging alternative for AF treatment with potential advantages in procedural time and lesion formation, though robust clinical validation is still ongoing.
No takes yet. Share an insight, caveat, or question.
May shorten AF ablation procedures; leaves open need for RCTs confirming safety and durability before routine adoption.
Kotadia et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: